RT Journal Article
SR Electronic
T1 Viral cultures for COVID-19 infectivity assessment – a systematic review
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.04.20167932
DO 10.1101/2020.08.04.20167932
A1 Jefferson, T
A1 Spencer, EA
A1 Brassey, J
A1 Heneghan, C
YR 2020
UL http://medrxiv.org/content/early/2020/08/04/2020.08.04.20167932.abstract
AB We report the results of a review of the evidence from studies comparing SARS-CoV-2 culture with reverse transcriptase polymerase chain reaction (rt-PCR), as viral culture represents the best indicator of current infection and infectiousness of the isolate.We identified fourteen studies succeeding in culturing or observing tissue invasion by SARS-CoV in sputum, naso or oropharyngeal, urine, stool and environmental samples from patients diagnosed with Covid-19.The data are suggestive of a relation between the time from collection of a specimen to test, copy threshold, and symptom severity, but the quality of the studies was moderate with lack of standardised reporting and lack of testing of PCR against viral culture or infectivity in animals. This limits our current ability to quantify the relationship between viral load, cycle threshold and viable virus detection and ultimately the usefulness of PCR use for assessing infectiousness of patients.Prospective routine testing of reference and culture specimens are necessary for each country involved in the pandemic to establish the usefulness and reliability of PCR for Covid-19 and its relation to patients’ factors such as date of onset of symptoms and copy threshold, in order to help predict infectivity.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://www.cebm.net/wp-content/uploads/2020/06/Protocol-Analysis-of-Transmission-Dynamics-of-COVID-1.pdf Funding StatementThe reviews was partly funded by NIHR Evidence Synthesis Working Group project 380 and supported by the Maria and David Willets foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable. Review of available evidenceAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data included in the review are from publications or preprints. All extractions sheets with direct links to the source paper are available from https://www.cebm.net/evidence-synthesis/transmission-dynamics-of-covid-19/ https://www.cebm.net/evidence-synthesis/transmission-dynamics-of-covid-19/